Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Study of an intratumoral delivery of NZ-DTX Depot in men with localized prostate cancer who are scheduled for prostatectomy

X
Trial Profile

Study of an intratumoral delivery of NZ-DTX Depot in men with localized prostate cancer who are scheduled for prostatectomy

Status: Planning
Phase of Trial: Phase I

Latest Information Update: 28 Feb 2024

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Docetaxel (Primary)
  • Indications Prostate cancer
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors LIDDS
  • Most Recent Events

    • 22 Feb 2024 According to a LIDDS media release, this study was never started due to the cost-cutting measures initiated in June.
    • 19 Apr 2021 New trial record
    • 16 Apr 2021 According to a LIDDS media release,the application for a new clinical study at Uppsala University Hospital has been submitted. Also, the study is planned to start in mid of this year having Dr. Michael Haggman (Associate Professor at the Department of Surgical Sciences in Urology) as a principal investigator.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top